{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:17:36Z","timestamp":1776475056987,"version":"3.51.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of the study was to evaluate potential chemotherapy-induced microsatellite instability, loss of heterozygosity, loss of expression in mismatch repair proteins and associations with clinical findings in breast cancer patients, especially resistance to chemotherapy and\/or development of other tumors in the four years following chemotherapy treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A comprehensive study of chemotherapy-related effects with a follow-up period of 48\u2009months post treatment was conducted. A total of 369 peripheral blood samples were collected from 123 de novo breast cancer patients. Microsatellite instability and loss of heterozygosity in five commonly used marker loci (including Tp53-Alu of the tumor suppressor gene TP53) were analyzed in blood samples. Sampling was conducted on three occasions; 4\u20135\u2009weeks prior to the first chemotherapy session (pre-treatment), to serve as a baseline, followed by two consecutive draws at 12\u2009weeks intervals from the first collection. Mismatch repair protein expression was evaluated in cancer tissues using immunohistochemistry for three mismatch-repair related proteins.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 70.7% of the patients showed microsatellite instability for at least one locus, including 18.6% marked as high-positive and 52.1% as low-positive; 35.8% showed loss of heterozygosity in addition to microsatellite instability, while 29.3% exhibited microsatellite stability. The following incidence rates for microsatellite instability and loss of heterozygosity were detected: 39.1% positive for Tp53-Alu, 31.1% for locus Mfd41, and 25.3% for locus Mfd28. A higher occurrence of loss of heterozygosity was noted with alleles 399 and 404 of Tp53-Alu. The mismatch repair protein expression analysis showed that the chemotherapy caused a loss of 29.3% in hMLH1 expression, and 18.7% and 25.2% loss in hMSH2 and P53 expression, respectively. A strong correlation between low or deficient hMSH2 protein expression and occurrence of mismatch repair\/loss of heterozygosity events in Mfd41, Tp53-Alu, and Mfd28 was evident. A significant association between mismatch repair\/loss of heterozygosity and incidence of secondary tumors was also established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results suggest that microsatellite instability, loss of heterozygosity, and deficiency in mismatch repair may serve as early prognostic factors for potential chemotherapy-related side effects in breast cancer patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-12-373","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T12:15:07Z","timestamp":1346156107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study"],"prefix":"10.1186","volume":"12","author":[{"given":"Nasir","family":"Kamat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Khidhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Jaloudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabir","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouied M","family":"Alashari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled H","family":"Al Qawasmeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Rannug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"issue":"5","key":"3378_CR1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1200\/JCO.2003.07.113","volume":"21","author":"JO Armitage","year":"2003","unstructured":"Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S: Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. J Clin Oncol. 2003, 21 (5): 897-906. 10.1200\/JCO.2003.07.113.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3378_CR2","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3324\/haematol.11034","volume":"92","author":"G Leone","year":"2007","unstructured":"Leone G, Pagano L, Ben-Yehuda D, Voso MT: Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica. 2007, 92 (10): 1389-1398. 10.3324\/haematol.11034.","journal-title":"Haematologica"},{"issue":"5","key":"3378_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/annonc\/mdg204","volume":"14","author":"C Bernard-Marty","year":"2003","unstructured":"Bernard-Marty C, Mano M, Paesmans M, Accettura C, Munoz-Bermeo R, Richard T, Kleiber K, Cardoso F, Lobelle JP, Larsimont D, et al: Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. Ann Oncol. 2003, 14 (5): 693-698. 10.1093\/annonc\/mdg204.","journal-title":"Ann Oncol"},{"issue":"5","key":"3378_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/08880018.2011.562601","volume":"28","author":"C Berger","year":"2011","unstructured":"Berger C, Trombert-Paviot B, Casagranda L, Mialou V, Frappaz D, Plantaz D, Collardeau-Frachon S, Freycon F: Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987\u20132004) from the childhood cancer registry of the Rhone-Alpes region (ARCERRA) in France. Pediatr Hematol Oncol. 2011, 28 (5): 364-379. 10.3109\/08880018.2011.562601.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"3378_CR5","doi-asserted-by":"publisher","first-page":"e2011031","DOI":"10.4084\/mjhid.2011.031","volume":"3","author":"F Ricci","year":"2011","unstructured":"Ricci F, Tedeschi A, Montillo M, Morra E: Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia. Mediterr J Hematol Infect Dis. 2011, 3 (1): e2011031-","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"16","key":"3378_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/jnci\/90.16.1205","volume":"90","author":"DR Budman","year":"1998","unstructured":"Budman DR, Berry DA, Cirrincione CT, Henderson IC, Wood WC, Weiss RB, Ferree CR, Muss HB, Green MR, Norton L, et al: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer, The Cancer and Leukemia Group B. J Natl Cancer Inst. 1998, 90 (16): 1205-1211. 10.1093\/jnci\/90.16.1205.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"3378_CR7","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1200\/JCO.2001.19.12.3103","volume":"19","author":"MJ Piccart","year":"2001","unstructured":"Piccart MJ, Di Leo A, Beauduin M, Vindevoghel A, Michel J, Focan C, Tagnon A, Ries F, Gobert P, Finet C, et al: Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. J Clin Oncol. 2001, 19 (12): 3103-3110.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3378_CR8","first-page":"937","volume":"84","author":"G Leone","year":"1999","unstructured":"Leone G, Mele L, Pulsoni A, Equitani F, Pagano L: The incidence of secondary leukemias. Haematologica. 1999, 84 (10): 937-945.","journal-title":"Haematologica"},{"issue":"3","key":"3378_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/bjc.2011.256","volume":"105","author":"CK Lee","year":"2011","unstructured":"Lee CK, Gurney H, Brown C, Sorio R, Donadello N, Tulunay G, Meier W, Bacon M, Maenpaa J, Petru E, et al: Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. Br J Cancer. 2011, 105 (3): 360-365. 10.1038\/bjc.2011.256.","journal-title":"Br J Cancer"},{"issue":"1","key":"3378_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ijc.25318","volume":"128","author":"JY Shi","year":"2011","unstructured":"Shi JY, Ren ZH, Jiao B, Xiao R, Yun HY, Chen B, Zhao WL, Zhu Q, Chen Z, Chen SJ: Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. Int J Cancer. 2011, 128 (1): 233-238. 10.1002\/ijc.25318.","journal-title":"Int J Cancer"},{"issue":"15","key":"3378_CR11","first-page":"5723","volume":"61","author":"B Taback","year":"2001","unstructured":"Taback B, Fujiwara Y, Wang HJ, Foshag LJ, Morton DL, Hoon DS: Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients. Cancer Res. 2001, 61 (15): 5723-5726.","journal-title":"Cancer Res"},{"issue":"7","key":"3378_CR12","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1182\/blood.V99.7.2387","volume":"99","author":"I Thornley","year":"2002","unstructured":"Thornley I, Sutherland R, Wynn R, Nayar R, Sung L, Corpus G, Kiss T, Lipton J, Doyle J, Saunders F, et al: Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss. Blood. 2002, 99 (7): 2387-2396. 10.1182\/blood.V99.7.2387.","journal-title":"Blood"},{"issue":"8","key":"3378_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2174\/138920208786847926","volume":"9","author":"WM Abdel-Rahman","year":"2008","unstructured":"Abdel-Rahman WM: Genomic instability and carcinogenesis: an update. Curr Genomics. 2008, 9 (8): 535-541. 10.2174\/138920208786847926.","journal-title":"Curr Genomics"},{"issue":"11","key":"3378_CR14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrg2828","volume":"11","author":"CT McMurray","year":"2010","unstructured":"McMurray CT: Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet. 2010, 11 (11): 786-799. 10.1038\/nrg2828.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"3378_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3748\/wjg.v17.i3.290","volume":"17","author":"S Nobili","year":"2011","unstructured":"Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F, Rubio CA, Mini E, Nesi G: Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol. 2011, 17 (3): 290-299. 10.3748\/wjg.v17.i3.290.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"3378_CR16","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1684\/bdc.2010.1216","volume":"97","author":"P Laurent-Puig","year":"2011","unstructured":"Laurent-Puig P, Agostini J, Maley K: Colorectal oncogenesis. Bull Cancer. 2011, 97 (11): 1311-1321.","journal-title":"Bull Cancer"},{"issue":"6","key":"3378_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PAP.0b013e3181bb6bdc","volume":"16","author":"AM Bellizzi","year":"2009","unstructured":"Bellizzi AM, Frankel WL: Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol. 2009, 16 (6): 405-417. 10.1097\/PAP.0b013e3181bb6bdc.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"3378_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1897-4287-7-10","volume":"7","author":"R Akoum","year":"2009","unstructured":"Akoum R, Ghaoui A, Brihi E, Ghabash M, Hajjar N: Early-onset breast cancer in a Lebanese family with Lynch syndrome due to MSH2 gene mutation. Hered Cancer Clin Pract. 2009, 7 (1): 10-10.1186\/1897-4287-7-10.","journal-title":"Hered Cancer Clin Pract"},{"issue":"3","key":"3378_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10689-004-1447-6","volume":"4","author":"LM Baudhuin","year":"2005","unstructured":"Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN: Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer. 2005, 4 (3): 255-265. 10.1007\/s10689-004-1447-6.","journal-title":"Fam Cancer"},{"issue":"14","key":"3378_CR20","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1158\/0008-5472.CAN-03-2879","volume":"64","author":"H Nakagawa","year":"2004","unstructured":"Nakagawa H, Lockman JC, Frankel WL, Hampel H, Steenblock K, Burgart LJ, Thibodeau SN, de la Chapelle A: Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res. 2004, 64 (14): 4721-4727. 10.1158\/0008-5472.CAN-03-2879.","journal-title":"Cancer Res"},{"issue":"11","key":"3378_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/jnci\/djr153","volume":"103","author":"FA Sinicrope","year":"2011","unstructured":"Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, Yothers G, Allegra C, Moore MJ, Gallinger S, et al: DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst. 2011, 103 (11): 863-875. 10.1093\/jnci\/djr153.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3378_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1758834010367905","volume":"2","author":"DA Bastos","year":"2010","unstructured":"Bastos DA, Ribeiro SC, de Freitas D, Hoff PM: Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects. Ther Adv Med Oncol. 2010, 2 (4): 261-272. 10.1177\/1758834010367905.","journal-title":"Ther Adv Med Oncol"},{"issue":"23","key":"3378_CR23","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andre","year":"2004","unstructured":"Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004, 350 (23): 2343-2351. 10.1056\/NEJMoa032709.","journal-title":"N Engl J Med"},{"key":"3378_CR24","first-page":"892182","volume":"2012","author":"IL Farias","year":"2011","unstructured":"Farias IL, Araujo MC, Farias JG, Rossato LV, Elsenbach LI, Dalmora SL, Flores NM, Durigon M, Cruz IB, Morsch VM, et al: Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial. Evid Based Complement Alternat Med. 2011, 2012: 892182-","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"3378_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1165\/ajrcmb.24.4.4206","volume":"24","author":"M Mori","year":"2001","unstructured":"Mori M, Kida H, Morishita H, Goya S, Matsuoka H, Arai T, Osaki T, Tachibana I, Yamamoto S, Sakatani M, et al: Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2001, 24 (4): 398-404.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"3378_CR26","first-page":"296","volume":"63","author":"AI Zavras","year":"2003","unstructured":"Zavras AI, Pitiphat W, Wu T, Cartsos V, Lam A, Douglass CW, Diehl SR: Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans. Cancer Res. 2003, 63 (2): 296-297.","journal-title":"Cancer Res"},{"issue":"4","key":"3378_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.cdd.4401193","volume":"10","author":"A Mrozek","year":"2003","unstructured":"Mrozek A, Petrowsky H, Sturm I, Kraus J, Hermann S, Hauptmann S, Lorenz M, Dorken B, Daniel PT: Combined p53\/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability. Cell Death Differ. 2003, 10 (4): 461-467. 10.1038\/sj.cdd.4401193.","journal-title":"Cell Death Differ"},{"issue":"23","key":"3378_CR28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","volume":"89","author":"MA Rodriguez-Bigas","year":"1997","unstructured":"Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, et al: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997, 89 (23): 1758-1762. 10.1093\/jnci\/89.23.1758.","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"3378_CR29","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998, 58 (22): 5248-5257.","journal-title":"Cancer Res"},{"issue":"4","key":"3378_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004, 96 (4): 261-268. 10.1093\/jnci\/djh034.","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"3378_CR31","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1158\/1078-0432.CCR-06-0547","volume":"12","author":"J Yu","year":"2006","unstructured":"Yu J, Mallon MA, Zhang W, Freimuth RR, Marsh S, Watson MA, Goodfellow PJ, McLeod HL: DNA repair pathway profiling and microsatellite instability in colorectal cancer. Clin Cancer Res. 2006, 12 (17): 5104-5111. 10.1158\/1078-0432.CCR-06-0547.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3378_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","volume":"11","author":"EGAPP","year":"2009","unstructured":"EGAPP: Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009, 11 (1): 35-41.","journal-title":"Genet Med"},{"issue":"4\u20135","key":"3378_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1155\/2004\/136734","volume":"20","author":"JW Bacher","year":"2004","unstructured":"Bacher JW, Flanagan LA, Smalley RL, Nassif NA, Burgart LJ, Halberg RB, Megid WM, Thibodeau SN: Development of a fluorescent multiplex assay for detection of MSI-High tumors. Dis Markers. 2004, 20 (4\u20135): 237-250.","journal-title":"Dis Markers"},{"issue":"1)","key":"3378_CR34","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/bcr950","volume":"7","author":"FL Fonseca","year":"2005","unstructured":"Fonseca FL, Sant Ana AV, Bendit I, Arias V, Costa LJ, Pinhal AA, del Giglio A: Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients. Breast Cancer Res. 2005, 7 (1)): R28-R32.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"3378_CR35","doi-asserted-by":"publisher","first-page":"e9393","DOI":"10.1371\/journal.pone.0009393","volume":"5","author":"A Goel","year":"2010","unstructured":"Goel A, Nagasaka T, Hamelin R, Boland CR: An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers. PLoS One. 2010, 5 (2): e9393-10.1371\/journal.pone.0009393.","journal-title":"PLoS One"},{"issue":"4","key":"3378_CR36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.18388\/abp.2003_3643","volume":"50","author":"J Powierska-Czarny","year":"2003","unstructured":"Powierska-Czarny J, Miscicka-Sliwka D, Czarny J, Grzybowski T, Wozniak M, Drewa G, Czechowicz W, Sir J: Analysis of microsatellite instability and loss of heterozygosity in breast cancer with the use of a well characterized multiplex system. Acta Biochim Pol. 2003, 50 (4): 1195-1203.","journal-title":"Acta Biochim Pol"},{"issue":"9","key":"3378_CR37","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1188\/02.ONF.E91-E98","volume":"29","author":"A Bener","year":"2002","unstructured":"Bener A, Honein G, Carter AO, Da'ar Z, Miller C, Dunn EV: The determinants of breast cancer screening behavior: a focus group study of women in the United Arab Emirates. Oncol Nurs Forum. 2002, 29 (9): E91-E98. 10.1188\/02.ONF.E91-E98.","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"3378_CR38","doi-asserted-by":"crossref","first-page":"612","DOI":"10.26719\/2009.15.3.612","volume":"15","author":"K Ravichandran","year":"2009","unstructured":"Ravichandran K, Al-Zahrani AS: Association of reproductive factors with the incidence of breast cancer in Gulf Cooperation Council countries. East Mediterr Health J. 2009, 15 (3): 612-621.","journal-title":"East Mediterr Health J"},{"issue":"21","key":"3378_CR39","first-page":"4749","volume":"57","author":"W Dietmaier","year":"1997","unstructured":"Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J: Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 1997, 57 (21): 4749-4756.","journal-title":"Cancer Res"},{"key":"3378_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/0471249688","volume-title":"categorical data analysis","author":"A Agresti","year":"2002","unstructured":"Agresti A: categorical data analysis. 2002, Wiley, New Jersey, 2","edition":"2"},{"issue":"10","key":"3378_CR41","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1093\/emboj\/20.10.2587","volume":"20","author":"E Viguera","year":"2001","unstructured":"Viguera E, Canceill D, Ehrlich SD: Replication slippage involves DNA polymerase pausing and dissociation. EMBO J. 2001, 20 (10): 2587-2595. 10.1093\/emboj\/20.10.2587.","journal-title":"EMBO J"},{"issue":"3","key":"3378_CR42","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1104\/pp.110.162933","volume":"154","author":"A Golubov","year":"2010","unstructured":"Golubov A, Yao Y, Maheshwari P, Bilichak A, Boyko A, Belzile F, Kovalchuk I: Microsatellite instability in Arabidopsis increases with plant development. Plant Physiol. 2010, 154 (3): 1415-1427. 10.1104\/pp.110.162933.","journal-title":"Plant Physiol"},{"issue":"13","key":"3378_CR43","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/hmg\/ddq175","volume":"19","author":"C Campregher","year":"2010","unstructured":"Campregher C, Scharl T, Nemeth M, Honeder C, Jascur T, Boland CR, Gasche C: The nucleotide composition of microsatellites impacts both replication fidelity and mismatch repair in human colorectal cells. Hum Mol Genet. 2010, 19 (13): 2648-2657. 10.1093\/hmg\/ddq175.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"3378_CR44","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/nar\/gkq829","volume":"39","author":"D Kumar","year":"2010","unstructured":"Kumar D, Abdulovic AL, Viberg J, Nilsson AK, Kunkel TA, Chabes A: Mechanisms of mutagenesis in vivo due to imbalanced dNTP pools. Nucleic Acids Res. 2010, 39 (4): 1360-1371.","journal-title":"Nucleic Acids Res"},{"issue":"6781","key":"3378_CR45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/35010014","volume":"404","author":"T Matsuda","year":"2000","unstructured":"Matsuda T, Bebenek K, Masutani C, Hanaoka F, Kunkel TA: Low fidelity DNA synthesis by human DNA polymerase-eta. Nature. 2000, 404 (6781): 1011-1013. 10.1038\/35010014.","journal-title":"Nature"},{"issue":"5109","key":"3378_CR46","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1126\/science.8484121","volume":"260","author":"LA Aaltonen","year":"1993","unstructured":"Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, et al: Clues to the pathogenesis of familial colorectal cancer. Science. 1993, 260 (5109): 812-816. 10.1126\/science.8484121.","journal-title":"Science"},{"issue":"4","key":"3378_CR47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/sj.bjc.6602708","volume":"93","author":"DA Lawes","year":"2005","unstructured":"Lawes DA, Pearson T, Sengupta S, Boulos PB: The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Br J Cancer. 2005, 93 (4): 472-477. 10.1038\/sj.bjc.6602708.","journal-title":"Br J Cancer"},{"key":"3378_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-4598-2-41","volume":"2","author":"S Narayan","year":"2003","unstructured":"Narayan S, Roy D: Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003, 2: 41-10.1186\/1476-4598-2-41.","journal-title":"Mol Cancer"},{"issue":"13","key":"3378_CR49","first-page":"3724","volume":"63","author":"T Kuroki","year":"2003","unstructured":"Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM: Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 2003, 63 (13): 3724-3728.","journal-title":"Cancer Res"},{"issue":"9","key":"3378_CR50","first-page":"2890","volume":"8","author":"Q Yang","year":"2002","unstructured":"Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Shimizu Y, Mori I, Sakurai T, Kakudo K: Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Clin Cancer Res. 2002, 8 (9): 2890-2893.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3378_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/02841860410002842","volume":"44","author":"J Smeds","year":"2005","unstructured":"Smeds J, Warnberg F, Norberg T, Nordgren H, Holmberg L, Bergh J: Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity. Acta Oncol. 2005, 44 (1): 41-49. 10.1080\/02841860410002842.","journal-title":"Acta Oncol"},{"issue":"10","key":"3378_CR52","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1158\/1078-0432.CCR-08-2249","volume":"15","author":"G Toffoli","year":"2009","unstructured":"Toffoli G, Biason P, Russo A, De Mattia E, Cecchin E, Hattinger CM, Pasello M, Alberghini M, Ferrari C, Scotlandi K, et al: Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin Cancer Res. 2009, 15 (10): 3550-3556. 10.1158\/1078-0432.CCR-08-2249.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3378_CR53","first-page":"1192","volume":"8","author":"M Furihata","year":"2002","unstructured":"Furihata M, Takeuchi T, Matsumoto M, Kurabayashi A, Ohtsuki Y, Terao N, Kuwahara M, Shuin T: p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract. Clin Cancer Res. 2002, 8 (5): 1192-1195.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3378_CR54","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/carcin\/bgi125","volume":"26","author":"HH Nelson","year":"2005","unstructured":"Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT: TP53 mutation, allelism and survival in non-small cell lung cancer. Carcinogenesis. 2005, 26 (10): 1770-1773. 10.1093\/carcin\/bgi125.","journal-title":"Carcinogenesis"},{"issue":"3","key":"3378_CR55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/humu.10180","volume":"21","author":"CM Fenoglio-Preiser","year":"2003","unstructured":"Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A: TP53 and gastric carcinoma: a review. Hum Mutat. 2003, 21 (3): 258-270. 10.1002\/humu.10180.","journal-title":"Hum Mutat"},{"issue":"3","key":"3378_CR56","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/bcr1675","volume":"9","author":"A Langerod","year":"2007","unstructured":"Langerod A, Zhao H, Borgan O, Nesland JM, Bukholm IR, Ikdahl T, Karesen R, Borresen-Dale AL, Jeffrey SS: TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res. 2007, 9 (3): R30-10.1186\/bcr1675.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"3378_CR57","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10585-011-9375-y","volume":"28","author":"EO Berge","year":"2011","unstructured":"Berge EO, Knappskog S, Lillehaug JR, Lonning PE: Alterations of the retinoblastoma gene in metastatic breast cancer. Clin Exp Metastasis. 2011, 28 (3): 319-326. 10.1007\/s10585-011-9375-y.","journal-title":"Clin Exp Metastasis"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-373\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:48:52Z","timestamp":1630615732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3378"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-373","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]},"assertion":[{"value":"24 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"373"}}